Nanoceria and thioredoxin regulate a common antioxidative gene network in tubby mice

Xue Cai1, Junji Yodoi, Sudipta Seal

  • 1Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, 73104, Oklahoma City, OK, USA, xue-cai@ouhsc.edu.

Insights

Nanoceria and thioredoxin (Trx) protect against retinal degeneration by regulating the same antioxidant defense genes in mice. This finding offers new insights into treating oxidative stress-related ocular diseases.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Nanotechnology

Background:

  • Oxidative stress contributes to various ocular diseases.
  • Thioredoxin (Trx) exhibits neuroprotective properties for photoreceptors.
  • Nanoceria (cerium oxide nanoparticles) demonstrate antioxidant capabilities and prevent retinal degeneration in tubby mice.

Purpose of the Study:

  • To investigate the gene expression changes in response to nanoceria treatment and Trx overexpression in the context of oxidative stress in ocular diseases.
  • To identify common regulatory pathways influenced by both nanoceria and Trx.

Main Methods:

  • Utilized commercially available PCR array plates to analyze the expression of 89 oxidative stress-associated genes.
  • Studied P12 tubby mice, comparing those intravitreally injected with nanoceria to those with Trx gene overexpression.

Main Results:

  • Both nanoceria and Trx overexpression modulated the expression of a shared set of genes.
  • These commonly regulated genes are involved in antioxidative stress and antioxidant defense mechanisms.

Conclusions:

  • Nanoceria and Trx converge on similar genetic pathways to combat oxidative stress in the retina.
  • These findings support the therapeutic potential of nanoceria and Trx in managing oxidative stress-related retinal degeneration.

Related Concept Videos